Sure, and they still think the drug has blockbuster potential. But BMY represents massive sales, Eliqius growth and their oncology lineup...They also have one state of the art new Biologic facility recently opened in Boston and they are constructing another one in Ireland.
Biolgics will create the longer streams of revenue post patent expiry.
News 
Market Data 
Discover 
